As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

A post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution ...

Facebook posts reveal more GI side effects from semaglutide drugs like Ozempic than Mounjaro, offering new insights into ...

A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and ...

The updated standard replaces three previous guidelines and reflects the latest thinking on tackling obesity through the ...

Novo Nordisk remains a strong buy despite share price dip, thanks to its robust drug pipeline, massive market potential, and ...

People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.

People using weight loss medication have been warned it is not a "quick fix" with many at risk of regaining their lost weight ...

Patients ending obesity medication or finishing a weight management programme should be offered support to help keep the ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

Thousands of patients desperate to access the “King Kong” of weight loss jabs are facing a postcode lottery, research reveals ...

Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy ...